Stock Market 20 May 2026 - 21 May 2026

Lichen International Stock Trades Higher Ahead of Nasdaq Open
····

Lichen International Stock Trades Higher Ahead of Nasdaq Open

Lichen International Limited shares were up in early U.S. trading after a choppy Tuesday session. The small Nasdaq-listed China financial-services stock continued a strong move, though there was little new company news out to explain the demand. The stock traded at $1.52, up 14 cents, or about 10% over the last close, according to market data. Shares opened Tuesday at $1.32 and swung from $1.26 to $1.71, Yahoo Finance data showed. Volume was around 543,580 shares.
June 3, 2026
AREC Stock Jumps as American Resources’ Rare-Earth Pivot Gets a 10-K Test
····

AREC Stock Jumps as American Resources’ Rare-Earth Pivot Gets a 10-K Test

American Resources Corp shares last traded unchanged at $2.14 in Thursday premarket dealings, the early session before the 9:30 a.m. New York open, after closing up 10.3% on Wednesday as investors weighed a delayed annual report and a cleaner rare-earth strategy. U.S. regular trading had not opened; Nasdaq’s 2026 calendar lists Memorial Day, May 25, as the next scheduled market closure. The filing matters now because it removes part of a compliance overhang. Nasdaq told American Resources on April 24 that it was not in compliance with Listing Rule 5250 because it had not filed its 2025 Form 10-K, an annual report with audited accounts and risk disclosures; the notice had no immediate effect on the stock’s listing or trading.
May 21, 2026
Flexsteel Faces Key Session After 3.5% Stock Gain
····

Flexsteel Faces Key Session After 3.5% Stock Gain

Flexsteel Industries shares are up 3.5% going into Thursday’s regular session. Management is set to meet investors later Thursday, putting the company’s big buyback and margins in the spotlight again. Flexsteel Industries, Inc. ended Wednesday at $55.24, gaining 3.52%. The stock hit $55.54 during the session, with 43,376 shares traded, according to LSEG data posted on the company’s investor site. Sidoti has Flexsteel set to present Thursday from 2:30 p.m. to 3:00 p.m. EDT.
May 21, 2026
LivePerson Stock Alert: LPSN Rebounds as SoundHound Deal and Insider Filings Put Shares on Watch
····

LivePerson Stock Alert: LPSN Rebounds as SoundHound Deal and Insider Filings Put Shares on Watch

LivePerson Inc. shares go into Thursday’s U.S. pre-market with the stock back at $2.07, after a modest bounce that did not erase Tuesday’s fall. The Nasdaq-listed customer-engagement software company closed up 3.0% Wednesday on volume of 97,378 shares, LivePerson investor data showed. This matters now because LPSN is trading less like a routine software earnings story and more like a pending deal stock. Nasdaq’s pre-market system was open in New York, regular trading runs from 9:30 a.m. to 4:00 p.m. ET, and Nasdaq’s 2026 holiday schedule lists Memorial Day, May 25, not Thursday, as the next full U.S. market closure.
May 21, 2026
First Advantage Stock Pops Again — But Investors Are Still Testing the Earnings Story
····

First Advantage Stock Pops Again — But Investors Are Still Testing the Earnings Story

First Advantage Corp shares head into Thursday’s pre-market session with fresh momentum after gaining 2.55% to $15.28 on Wednesday, as investors kept working through the background-screening company’s stronger first-quarter results and a more mixed outside view on valuation. The move matters now because the stock has been climbing with the broader market but is still being judged against a big question: whether First Advantage can turn post-Sterling scale, cost savings and digital-identity demand into steadier profit growth. Nasdaq lists regular trading from 9:30 a.m. to 4 p.m. Eastern time, with pre-market trade starting at 4 a.m.; the next U.S. market holiday is Memorial Day on May 25.
May 21, 2026
RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround
····

RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround

RxSight Inc. trades higher Thursday morning. The ophthalmic device stock finished at $6.160 on Wednesday, a gain of 3.53%. Even with that bounce, shares are down 40.88% year-to-date. Execution is the key test in the near term, not launching something new. RxSight said management will join a fireside chat at the Stifel 2026 Virtual Ophthalmology Forum on May 26. The event gives investors a set time to see if the company’s sales reset has momentum.
May 21, 2026
iOThree (IOTR) shares draw attention again
····

iOThree (IOTR) shares draw attention again

iOThree Ltd shares finished at $1.99 on Nasdaq, up 9 cents, or 4.7%. The Singapore maritime-technology micro-cap was drawing some attention ahead of Thursday’s regular session in the U.S. MarketScreener listed the stock at $1.990 at 4:30 p.m. EDT Wednesday. Latest quotes also had it at $1.99. Timing is key. Nasdaq regular trading hadn't started yet in New York. The current schedule puts pre-market at 4:00 a.m. to 9:30 a.m. ET, regular at 9:30 a.m. to 4:00 p.m., and then post-market to 8:00 p.m. May 21 isn't a holiday for Nasdaq in 2026, though U.S. markets will be shut for Memorial Day on May 25.
May 21, 2026
Star Bulk Stock Gets a Dividend Jolt as SBLK Cash Returns Take Center Stage
····

Star Bulk Stock Gets a Dividend Jolt as SBLK Cash Returns Take Center Stage

Star Bulk Carriers Corp. shares held near Wednesday’s gain in early U.S. pre-market trade after the dry-bulk shipper reported a sharp first-quarter profit rebound and a higher quarterly dividend. The Nasdaq-listed stock closed at $26.69, up 2.34%, and was quoted at $26.70 before regular trading opened. The move matters now because the earnings put hard numbers behind Star Bulk’s full-payout dividend policy, a draw for investors in a shipping segment where cash flow can swing with freight rates. Dry bulk means unpackaged cargo such as iron ore, grain and minerals; Star Bulk uses time-charter equivalent, or TCE, as a measure of average daily net revenue after voyage costs.
May 21, 2026
KALA Bio Shares Stir on Reverse Split Watch
····

KALA Bio Shares Stir on Reverse Split Watch

KALA Bio shares moved higher Wednesday, stretching a volatile streak for the small biotech. The company finished a big reverse stock split and told investors it's leaning harder into an artificial intelligence platform aimed at life-science companies. The stock traded at $2.65, up 9 cents, after moving in a range from $2.53 to $2.85. Volume was 88,886 shares. The thin trading can make moves bigger in small caps.
May 21, 2026
NAII Stock Gains Despite Wider Loss, Cash Still the Focus
····

NAII Stock Gains Despite Wider Loss, Cash Still the Focus

Natural Alternatives International Inc. stock gained Wednesday, though the nutritional supplements maker posted a larger fiscal third-quarter loss. Investors looked past the loss, focusing on higher sales, slimmer margins, and news of new refinancing. NAII shares last changed hands at $2.59, about 1.8% higher, with 10,040 shares traded. The company has a market cap close to $15.6 million. NAII is still in micro-cap territory, which means it carries a small market value and usually sees thin trading.
May 21, 2026
CG Oncology Shares Gain Ahead of Bladder Cancer Update; Wolfe Urges Caution
···

CG Oncology Shares Gain Ahead of Bladder Cancer Update; Wolfe Urges Caution

CG Oncology shares edged higher Wednesday as traders looked for direction and watched for the next update on its bladder-cancer drug, cretostimogene grenadenorepvec. The stock was recently quoted at $64.76, up 2.3%. Volume was near 768,000 shares. CG Oncology isn’t just a small biotech with a long runway anymore. The stock now trades around a near-term trial readout, a planned regulatory filing, and early Wall Street arguments over how quickly the drug could move if it wins approval. The company said it plans a biologics license application, or BLA, which is the main U.S. route for getting a biologic medicine cleared.
May 20, 2026
Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame
····

Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame

Esperion Therapeutics shares stayed flat at $3.13 late Wednesday, just under Archimed’s $3.16-a-share cash offer. Investors are looking at what’s left in the take-private deal and the open milestone risks. The stock moved in a tight range from $3.13 to $3.14, with volume topping 7 million shares. Esperion isn’t just a small-cap drug name trading on growth anymore. Now it’s more of a merger spread play, with shares moving on the gap between the deal price and where it trades. The spread’s slim, but still there.
May 20, 2026
ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data
······

ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data

argenx SE’s U.S. shares inched up Wednesday, trailing the biotech sector after Immunovant released rheumatoid-arthritis data that drew new focus to the same drug class as argenx’s VYVGART franchise. ARGX was trading at $803.67 near the end of the session, up 0.7%. The iShares Nasdaq Biotechnology ETF added 2.1% and SPDR S&P Biotech ETF climbed 3.8%. Shares of Immunovant soared 35.1%. Roivant Sciences, Immunovant’s parent, rose 14.6%, according to market data.
May 20, 2026
Ituran Shares Tick Higher Ahead of Results
····

Ituran Shares Tick Higher Ahead of Results

Ituran Location and Control Ltd. shares edged up 0.39% to $57.17 Wednesday on Nasdaq. Investors are waiting for the vehicle-telematics company’s first-quarter report next week. Around 77,164 shares changed hands. The company has a market cap near $1.14 billion. Shares finished below their 52-week high of $62.31. Ituran’s move is getting attention with its earnings report set for six days from now. The company is due to post Q1 2026 results on May 26 and will hold a management call for investors at 9 a.m. Eastern. Management will discuss results and take questions.
May 20, 2026
CoinShares Shares Recover After $1 Billion Fund Exit Hits Nasdaq Debutant
····

CoinShares Shares Recover After $1 Billion Fund Exit Hits Nasdaq Debutant

CoinShares PLC shares bounced back Wednesday, recovering some ground after a steep drop. Investors looked at another round of outflows from crypto funds and the firm’s move to attract U.S. institutions following its Nasdaq debut. The stock rose 3.3% to $5.33 on the Nasdaq in afternoon trading. Session range was $5.17 to $5.405. About 172,000 shares changed hands by late afternoon, below volumes in bigger crypto-linked stocks. Bitcoin traded close to $77,354, with ether near $2,130.
May 20, 2026
Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert
····

Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert

Immutep Ltd’s Nasdaq ADRs dropped around 5% Wednesday afternoon, missing out on gains in the biotech sector. New investor-law firm notices added to investor focus on lawsuits over the failed lung-cancer trial. The ADRs last changed hands at $0.4778, off a low of $0.4606. The SPDR S&P Biotech ETF climbed about 3.5%. Immutep is under pressure as it deals with a stock price below $1 on Nasdaq, shareholder litigation notices and efforts to recover trust following the halt of its TACTI-004 Phase III trial in first-line non-small cell lung cancer in March. Nasdaq’s regular U.S. market hours are 9:30 a.m. to 4 p.m. Eastern, according to Nasdaq.
May 20, 2026
Exelixis Up After Merck Pact Focuses Attention on Cancer Study
·····

Exelixis Up After Merck Pact Focuses Attention on Cancer Study

Exelixis shares climbed Wednesday after the company announced a new Merck partnership, putting its next cancer drug program further into late-stage trials. Shares traded 2.5% higher at $49.89 in the afternoon, putting the Alameda, California-based company’s market cap near $13.3 billion. Biotech stocks were strong, with the iShares Nasdaq Biotechnology ETF up 1.8% and the SPDR S&P Biotech ETF up 3.8%.
May 20, 2026
1 … 18 19 20 21 22 … 127